Clinical Trials Directory

Trials / Completed

CompletedNCT00394797

Surgical Correction of Moderate Ischemic Mitral Regurgitation

Status
Completed
Phase
Study type
Observational
Enrollment
Sponsor
Shaare Zedek Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The purpose of this study is to try and determine whether repair of moderate ischemic mitral regurgitation at the time of coronary bypass graft surgery (CABG) has an impact on survival.We will compare patients undergoing CABG + mitral repair or CABG only groups. Primary endpoints include late survival. Secondary endpoints include event free survival, symptoms, and echocardiographic outcomes.

Conditions

Interventions

TypeNameDescription
PROCEDUREmitral valve annuloplasty

Timeline

First posted
2006-11-01
Last updated
2011-06-01

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00394797. Inclusion in this directory is not an endorsement.